SG Americas Securities LLC Acquires 97,235 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

SG Americas Securities LLC boosted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 713.3% in the fourth quarter, Holdings Channel reports. The firm owned 110,866 shares of the company’s stock after purchasing an additional 97,235 shares during the quarter. SG Americas Securities LLC’s holdings in Acadia Healthcare were worth $4,396,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. State Street Corp grew its stake in shares of Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after buying an additional 95,613 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after buying an additional 454,044 shares during the period. LMR Partners LLP acquired a new position in shares of Acadia Healthcare in the 3rd quarter valued at about $1,616,000. Principal Financial Group Inc. grew its position in shares of Acadia Healthcare by 2.1% during the 3rd quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after buying an additional 13,368 shares during the period. Finally, Sivik Global Healthcare LLC grew its holdings in Acadia Healthcare by 43.7% in the third quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock worth $7,292,000 after purchasing an additional 34,997 shares during the period.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price objective for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. KeyCorp raised shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price target on the stock in a report on Tuesday, January 7th. Finally, Barclays cut their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research note on Friday, November 22nd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $44.18 on Friday. The stock has a market cap of $4.10 billion, a price-to-earnings ratio of 14.49, a PEG ratio of 1.79 and a beta of 1.29. Acadia Healthcare Company, Inc. has a 52 week low of $36.50 and a 52 week high of $87.77. The business has a 50-day simple moving average of $41.15 and a two-hundred day simple moving average of $56.43. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company had revenue of $815.60 million for the quarter, compared to the consensus estimate of $819.42 million. During the same period in the previous year, the business earned $0.91 earnings per share. The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, analysts expect that Acadia Healthcare Company, Inc. will post 3.39 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.